Production (Stage)
Pangenomic Health Inc.
NARA
CNSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 481.40K | 424.90K | 188.80K | 263.40K | 371.90K |
| Gross Profit | -481.40K | -424.90K | -188.80K | -263.40K | -371.90K |
| SG&A Expenses | 448.20K | 389.00K | 606.60K | 666.20K | 997.00K |
| Depreciation & Amortization | 4.00K | 6.20K | 8.40K | 9.20K | 9.20K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 938.60K | 807.20K | 815.00K | 949.20K | 1.43M |
| Operating Income | -938.60K | -807.20K | -815.00K | -949.20K | -1.43M |
| Income Before Tax | -2.89M | -2.77M | -2.57M | -2.72M | -1.58M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.89 | -2.77 | -2.57 | -2.72 | -1.58 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.89M | -2.77M | -2.57M | -2.72M | -1.58M |
| EBIT | -938.60K | -807.20K | -815.00K | -949.20K | -1.43M |
| EBITDA | -934.50K | -800.90K | -806.50K | -939.90K | -1.42M |
| EPS Basic | -0.51 | -0.54 | -0.63 | -0.76 | -0.79 |
| Normalized Basic EPS | -0.11 | -0.13 | -0.21 | -0.29 | -0.49 |
| EPS Diluted | -0.51 | -0.54 | -0.63 | -0.76 | -0.79 |
| Normalized Diluted EPS | -0.11 | -0.13 | -0.21 | -0.29 | -0.49 |
| Average Basic Shares Outstanding | 24.61M | 19.47M | 16.14M | 11.73M | 8.12M |
| Average Diluted Shares Outstanding | 24.61M | 19.47M | 16.14M | 11.73M | 8.12M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |